5 Most Common Uses for Medical Cannabis in 65+ Demographic
Seniors are among one of the largest existing and largest growing demographics of medical cannabis users , evidenced by international trends as well as is supported by the data collected from the Strainprint app. A report released late 2017 by Statistics Canada, indicated that older generations are the demographics consuming larger amounts of cannabis within […]
Daily Marijuana Observer – Better Know a CTO
Our President and Chief Technology Officer, Dave Berg was recently featured in the The Daily Marijuana Observer – Get to know all about what makes Dave tick, and why he’s so passionate about Strainprint.
5 Unique Facts About Cannabidiol (CBD)
When talking about cannabis, there are two main cannabinoids that make their way into most cannabis discourses: THC and CBD. While each are of equal value amongst the hundreds of cannabinoid compounds within the cannabis plant, they serve very different functions for the user and achieve different effects.
Strainprint Launches Custom App Version For Canna Farms
Strainprint™ — the leader in cannabis data collection and strain efficacy reporting — is pleased to announce the release of the Canna Farms OEM version of the Strainprint mobile App. The newest custom-branded version of the Strainprint App is available exclusively for Canna Farms customers through a unique activation code.
Weedbox – Wanna Smoke More of the Right Weed?
Weedbox – Wanna Smoke More of the Right Weed? There’s An App for That! Recently, Strainprint was featured on Weedbox. Stephanie Karasick, Founder of Strainprint was interviewed about the app. Read her full interview and learn all about Strainprint below! View Article
Stephanie Karasick On The 420 Radio Show
On Friday, November 10th Strainprint Founder, Stephanie Karasick appeared on the 420 Radio Show. Get more information, or to listen to the full interview here!
Strainprint Announces The Formation of A Board of Medical Advisors
Strainprint™, the leader in cannabis data collection, is pleased to welcome Dr. Lyle Oberg, Dr. Sana-Ara Ahmed, and Dr. HJ Raza to its Board of Medical Advisors. Strainprint™ works closely with its medical advisors to support patients, enhance research and advance the scientific understanding of cannabinoid therapy.
Strainprint Announces Partnership With Emblem Cannabis Corp.
Strainprint Technologies Ltd. (“Strainprint”) — the leader in cannabis patient and strain efficacy data — is excited to announce the launch of the first ever co-branded version of its revolutionary mobile outcomes-tracking App with Emblem Cannabis Corp.
Strainprint Closes Private Investment Round
Strainprint, the leader in cannabis patient and strain efficacy data, is pleased to announce that it has recently closed a private investment round. The Company plans to use proceeds to aggressively build brand and presence in legal North American markets through education and awareness campaigns.